ByHeart Executives Acquire Perrigo Infant Formula Unit

A purchasing group led by ByHeart leadership has reached an agreement to acquire the infant formula business of Perrigo.

Updated on Oct. 29, 2026 in Healthcare

Polished stainless steel industrial pipes inside a sterile manufacturing plant, representing the infant nutrition production industry.
Executives led by ByHeart have finalized an agreement to acquire the infant formula business unit from Perrigo for $175 million. AI Illustration. Upload story photo >

Live Poll

Should large companies be allowed to consolidate the infant formula market?

Executives led by ByHeart have finalized a purchase agreement to acquire the infant formula business from Perrigo Co. The deal is valued at up to $175 million.

Why it matters

The acquisition represents a significant consolidation in the specialized market for infant nutrition. By taking over the Perrigo unit, the leadership group expands its footprint in the critical sector of infant formula production.

The acquisition deal carries a maximum valuation of $175 million. This price reflects the agreed-upon total for the transfer of the infant formula business from Perrigo.

The players

Ron Belldegrun

He is an executive leading the acquisition group that purchased the infant formula business.

Mia Funt

She is an executive leading the purchasing entity in the acquisition of the Perrigo unit.

ByHeart

This is an infant nutrition company whose leadership group headed the acquisition effort.

Perrigo Co.

This is a consumer self-care company that sold its infant formula business division.

The details

Executives Ron Belldegrun and Mia Funt are heading the purchasing entity that successfully negotiated the deal with Perrigo. This transition marks a major change in ownership for the established infant formula business line.

Timeline

  1. October 29, 2026: Perrigo announced the infant formula business sale.

Market Landscape

The acquisition occurs within the regulatory framework established by the Infant Formula Safety and Inspection Modernization Act, which governs the production standards for infant nutrition companies in the United States. This move positions the new owners to compete more aggressively in an industry where stringent compliance and supply chain reliability are paramount.

Consumers who rely on products previously under the Perrigo brand may eventually see changes in product availability or retail branding as the new ownership integrates the business. At this stage, there is no immediate change to retail pricing for shoppers purchasing formula products.

The takeaway

This acquisition signals a shifting competitive environment for infant nutrition providers in the domestic market. Buyers should monitor the market for potential branding transitions as the new leadership takes control of the product line.

Further reading

For more information on the evolving sector of medical and wellness production, visit United States Healthcare.

Source note: This article includes information reported by Bloomberg Business.

Live Poll

Should large companies be allowed to consolidate the infant formula market?